Continuous variant reclassification: An effective tool in the ongoing quest to escape genetic purgatory
Genotype, albeit to varying degrees, affects the diagnosis, risk stratification, and management of many genetic heart diseases (GHDs).1 Accordingly, since the start of the new millennium, genetic testing has evolved from a research-based investigational test to a class I recommended, standard-of-care clinical test for patients with inherited cardiac channelopathies and cardiomyopathies such as arrhythmogenic cardiomyopathy, catecholaminergic polymorphic ventricular tachycardia, dilated cardiomyopathy, hypertrophic cardiomyopathy, and long QT syndrome (LQTS).
Source: Heart Rhythm - Category: Cardiology Authors: Michael J. Ackerman, John R. Giudicessi Tags: Editorial Commentary Source Type: research
More News: Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | Genetics | Heart | Hypertrophic Cardiomyopathy | Long QT Syndrome | Ventricular Tachycardia